Sibylle J. Hauske

Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function

Faı̈ez Zannad, João Pedro Ferreira, Stuart Pocock et al. · Circulation · 2020 · 278 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob Mice

Thomas Albrecht, Maaike Schilperoort, Shiqi Zhang et al. · Scientific Reports · 2017 · 127 citations · Full text

Medicine, Endocrinology, Pharmacology +17

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Adeera Levin, Rajiv Agarwal, William G. Herrington et al. · Kidney International · 2020 · 118 citations · Full text

Medicine, Nephrology, Dialysis +16

The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial

Parminder K. Judge, Katherine R. Tuttle, Natalie Staplin et al. · Nephrology Dialysis Transplantation · 2024 · 59 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes

Gregory A. Nichols, Anouk Déruaz‐Luyet, Kimberly G. Brodovicz et al. · BMC Nephrology · 2020 · 46 citations · Full text

Medicine, Internal Medicine, Nephrology +17